Oral linezolid for mrsa bacteremia

aureus infection are discussed separately. According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST), S

2024-03-29
    Donda revie
  1. aureus bacteremia are discussed further separately
  2. 12 years or older: 600 mg orally every 12 hours
  3. Abstract
  4. Linezolid is a synthetic oxazolidinone antimicrobial drug
  5. 7 Antimicrobial options for persistent S
  6. Introduction
  7. 2% for linezolid and 13
  8. 8 mg/kg per dose
  9. 6%) were superior to vancomycin outcomes (97/145 patients or 66
  10. 4% in the SPT group) or the 30-day mortality rate (2
  11. ;
  12. MRSA bone and joint infections 6